IQVIA Launches AI Platform to Transform Life Sciences
Research Triangle Park, North Carolina, March 16, 2026 IQVIA Holdings Inc. announced the launch of IQVIA.ai, a next-generation unified...
AI in Healthcare Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
Research Triangle Park, North Carolina, March 16, 2026 IQVIA Holdings Inc. announced the launch of IQVIA.ai, a next-generation unified...
PLEASANTON, CA — March 10, 2026 Veeva Systems announced the acquisition of Ostro, a leading AI-driven brand engagement platform...
DUBLIN, Feb. 13, 2026 — A new two-day virtual Life Science Technical Accounting Update Training Conference 2026 has been...
